Drug Profile
ABT 288
Alternative Names: ABT-288Latest Information Update: 28 Jul 2015
Price :
$50
*
At a glance
- Originator Abbott Laboratories
- Class Antipsychotics
- Mechanism of Action Neurotransmitter receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Alzheimer's disease; Schizophrenia